Sharon Bio-Medicine is locked at upper circuit limit at Rs. 11.62, up by 1.93 points or 19.92% from its previous closing of Rs. 9.69 on the BSE.
The scrip opened at Rs. 9.98 and has touched a high and low of Rs. 11.62 and Rs. 9.98 respectively. So far 2,12,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 32.55 on 16-Dec-2015 and a 52 week low of Rs. 8.40 on 02-Jun-2016.
Last one week high and low of the scrip stood at Rs. 11.62 and Rs. 9.00 respectively. The current market cap of the company is Rs. 122.67 crore.
The promoters holding in the company stood at 52.26%, while Institutions and Non-Institutions held 5.36% and 42.38% respectively.
Sharon Bio-Medicine has received an approval to introduce more profitable products, increase capacity utilization and get the business to move in the regulated markets specifically in the United States of America (USA). The board of directors at its meeting held on June 21, 2016 has decided for the same.
Sharon Bio-Medicine is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |